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Abstract
Apoptosis is essential to prevent oncogenic transformation by triggering self-destruction of harmful cells, including those
unable to differentiate. However, the mechanisms linking impaired cell differentiation and apoptosis during development
and disease are not well understood. Here we report that the Drosophila transcription factor Cut coordinately controls
differentiation and repression of apoptosis via direct regulation of the pro-apoptotic gene reaper. We also demonstrate that
this regulatory circuit acts in diverse cell lineages to remove uncommitted precursor cells in status nascendi and thereby
interferes with their potential to develop into cancer cells. Consistent with the role of Cut homologues in controlling cell
death in vertebrates, we find repression of apoptosis regulators by Cux1 in human cancer cells. Finally, we present evidence
that suggests that other lineage-restricted specification factors employ a similar mechanism to put the brakes on the
oncogenic process.
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Introduction
It has been a long-standing paradigm that impaired cell fate
commitment is a key initiator of cancer development [1,2], since
cancer cells display reduced differentiation properties compared to
normal cells, while tumor formation can be suppressed by
inducing the terminal cell fate in cancer cells [3]. The molecular
basis of the interplay between cell differentiation and cancer has
only recently been established. Bossuyt and colleagues (2009)
demonstrated that loss of the proneural transcription factor Atonal
not only leads to a loss of differentiated eye tissue but also
promotes tumor formation and progression in this tissue context
[4]. Thus, their work provided evidence that the maintenance of a
differentiated state, which is critically controlled by a cell-type
specification factor, is one crucial aspect to prevent the oncogenic
process, whereas loss of this master regulator, together with other
mutations creating a sensitized background, leads to the initiation
of tumorigenesis. In order to evade tumor development, organisms
have evolved potent mechanisms to protect themselves from the
effects of mutations in their soma [5]. Programmed cell death, or
apoptosis, plays a crucial role in removing abnormal cells, which
could develop into tumors. This is supported by the observation
that most types of cancers are associated with genetic alterations
that deactivate this rescue pathway, most commonly via up-
regulation of anti-apoptotic genes [6].
Since loss of terminal differentiation and the inability to activate
apoptosis are crucial steps in cancer development, the existence of
regulatory mechanisms preventing the accumulation of cells
harboring mutations in both pathways seems essential for the
survival of multi-cellular organisms. Consistently, mutations in
differentiation genes very often result in the activation of the
programmed cell death machinery [7,8]. However, the mecha-
nisms linking loss of differentiation and induction of apoptosis,
which is crucial for the prevention of tumor formation, are still
missing. Here we have used the Drosophila posterior spiracle (PS) as
a model to analyze the interplay of differentiation and apoptosis at
the mechanistic level. By studying the morphogenesis of this organ,
we have identified a hard-wired program through which the cell-
type specifying transcription factor Cut (Ct) controls in a subset of
PS cells, the filzko ¨rper cells, initiation of differentiation and
simultaneous repression of apoptosis via the direct transcriptional
regulation of the pro-apoptotic gene rpr. Using two well-established
Drosophila in vivo eye cancer models, we demonstrate that this
regulatory circuit instructed by the transcription factor Ct is a very
potent mechanism to prevent and/or reduce tumor growth, as it
allows the lineage-specific removal of abnormal cells at the time of
their genesis. Moreover, our data show that a related regulatory
wiring is used in vertebrates and that other cell-type specification
factors might employ a similar mechanism for tumor suppression,
thus suggesting that the coupling of differentiation and apoptosis
by individual transcription factors is a widely used and
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wired into the developmental program.
Results
Cut inhibits rpr expression and induction of apoptosis in
the PS
The PS connects the Drosophila respiratory system to the
environment and consists of an internal tube, the spiracular
chamber with a refractile filter, the filzko ¨rper, which is specified
by the transcription factor Ct, and an external protrusion in which
thespiracularchamberislocated,thestigmatophore,which isunder
the control of the transcription factor Spalt (Sal) (Figure 1A; Figure
S1A–S1D) [9]. In 1
st instar ct mutant larvae filzko ¨rper cells are not
detectable (Figure 2A, 2D; Figure S5A, S5B), which a priori suggests
that Ct is primarily required for the specification of the filzko ¨rper
cell fate. However, due to the fact that Ct has also been shown to
regulate programmed cell death[7],weassumed thatfilzko ¨rpercells
in ct mutant embryos could be completely missing due to the
induction of apoptosis. To test this hypothesis, we analyzed the
expression of all Drosophila pro-apoptotic genes, which revealed the
specific repression of reaper (rpr) (Figure 1B, 1C; Figure S1E, S1F;
Figure S2A, S2B) but not of head involution defective (hid), grim and sickle
(skl) (Figure S1I–S1N) transcription by Ct in embryonic filzko ¨rper
precursor cells. Strikingly, we only observed rpr de-repression in Ct-
positive filzko ¨rper, but never in Ct-neighboring, Sal-positive
stigmatophore precursor cells (Figure 1B, 1C; Figure S1E, S1F),
evidencing the cell-autonomous regulationof rpr byCt. Rprbinds to
Inhibitor of Apoptosis Protein (IAP), thereby releasing inhibition of
caspases and promoting apoptosis [10]. Consistently we could
demonstrate enhanced cell death in ct deficient filzko ¨rper precursor
cells of stage 11 embryos using the genetically-encoded caspase
reporter Apoliner [11] as well as TUNEL and Acridine Orange
(AO) stainings (Figure 1D, 1E, 1F, 1G; Figure S2G, S2H). Thus, rpr
de-repression is followed by apoptosis induction in ct mutant
embryos. To study the interplay between cell-type specification and
cell death at the mechanistic level, we identified conserved Ct-
dependent regulatory regions in the rpr intergenic regions using
computational methods. Due to the principal requirement of the
Hox transcription factor Abdominal-B (Abd-B) for PS development
[9], we searched for clusters of binding sites for Abd-B and Ct and
found a highly conserved 571 bp DNA element close to the rpr
coding region, which we termed rpr-HRE-571 (Figure S4).
Sequence-specific interaction of recombinant Ct protein with part
of the enhancer module, the S2 sub-fragment, was detected by
electrophoretic mobility shift assays (Figure 1K; Figure S1G).
Immunostainings revealed rpr-HRE-571-GFP activity solely in
stigmatophore (Figure 1I, 1L; Figure S3A, S3E, S3I, S3M) but
not in Ct-positive filzko ¨rper precursor cells (Figure 1L; Figure S3A,
S3E, S3I,S3M), that do not express rpr (Figure 1B, 1H;Figure S1E).
To validate the in vivo interaction of Ct with the identified enhancer
module, we interfered with Ct-enhancer interaction in two ways: we
mutated Ct binding sites within the rpr-HRE-571-S2 fragment
(Figure 1J), a truncated module with identical activity as the rpr-
HRE-571 enhancer (Figure 1M; Figure S3B, S3F, S3J, S3N), and
eliminated all three sites in a small deletion version of the rpr-HRE-
571 enhancer, termed rpr-HRE-571-S1 (Figure 1J). In both cases,
GFP expression was ectopically activated in Ct-positive filzko ¨rper
precursor cells (Figure 1N, 1O; Figure S3C, S3D, S3G, S3H, S3K,
S3L, S3O, S3P). These experiments demonstrated that Ct directly
represses rpr transcription and thus apoptosis in the filzko ¨rper
precursorcellsofthePSinacell-autonomousmannerbyinteracting
with a small enhancer module located in the rpr intergenic region.
Repression of apoptosis by Ct is required for
differentiation of filzko ¨rper cells
Since our result showed that filzko ¨rper cells are very efficiently
eliminated by apoptosis in the absence of Ct function, we next
asked whether Ct primarily acts as a repressor of programmed cell
death or whether this factor is also required for the differentiation
of filzko ¨rper cells. To this end, we analyzed ct deficient cells, which
were kept alive by expressing the caspase inhibitor p35 [12] in ct
mutant embryos using the PS-specific driver ems-GAL4 [13]. In
order to follow the cells normally under the control of Ct, these
cells were GFP-labeled using the same driver, which is active only
in a subset of Ct-expressing cells (Figure 2G, 2K). Our experiments
revealed that Ct- and GFP-positive filzko ¨rper cells found in the
wild-type situation (Figure 2A, 2F, 2F9, 2B, 2G, 2G9, 2K; Figure
S5A, S5D, S5G) are eliminated in ct mutant embryos (Figure 2D,
2I, 2I9, 2L; Figure S5B, S5E, S5H), whereas they remained viable
when apoptosis is blocked (ct
2; ems::p35) (Figure 2E, 2J, 2J).
However, these ct deficient, undead cells had developmental
defects, as they did not properly invaginate and did not acquire
their terminal cell fate as indicated by reduced expression of the
apical cell polarity marker Crumbs (Crb) and the cell adhesion
molecule DE-Cadherin (Figure 2F9,2 J 9; Figure S5D, S5F, S5G,
S5I). Consistently, these cells never adopted a filzko ¨rper cell fate
(Figure 2E; Figure S5C). These defects were a consequence of
blocking cell death in ct deficient, undifferentiated cells and were
not due to a general response to the apoptosis inhibitor p35, as the
filzko ¨rper of ems::p35 control embryos (Figure 2B, 2G, 2G9) was
indistinguishable form those of wild-type embryos (Figure 2A, 2F,
2F9). Local activation of apoptosis was sufficient to induce cell
death in filzko ¨rper cells, as expression of a rpr transgene resulted in
their elimination (Figure 2C, 2H, 2H9). Taken together, our results
revealed that Ct carries out two functions during PS morphogen-
esis: it allows the survival of uncommitted precursor cells by the
transcriptional repression of the pro-apoptotic gene rpr and
subsequently it drives these cells into a filzko ¨rper-specific cell fate.
Author Summary
Apoptosis is a highly conserved cellular function to remove
excessive or unstable cells in diverse developmental
processes and disease-responses. An important example
is the elimination of cells unable to differentiate, which
have the potential to generate tumors. Despite the
significance of this process, the mechanisms coupling loss
of differentiation and apoptosis have remained elusive.
Using cell-type specification in Drosophila as a model, we
now identify a conserved regulatory logic that underlies
cell-type specific removal of uncommitted cells by
apoptosis. We find that the transcription factor Cut
activates differentiation, while it simultaneously represses
cell death via the direct regulation of a pro-apoptotic
gene. We show that this regulatory interaction occurs in
many diverse cell types and is essential for normal
development. Using in vivo Drosophila cancer models, we
demonstrate that apoptosis activation in differentiation-
compromised cells is an immediate-early cancer preven-
tion mechanism. Importantly, we show that this type of
regulatory wiring is also found in vertebrates and that
other cell-type specification factors might employ a similar
mechanism for tumor suppression. Thus, our findings
suggest that the coupling of differentiation and apoptosis
by individual transcription factors is a widely used and
evolutionarily conserved cancer prevention module, which
is hard-wired into the developmental program.
Apoptosis Regulation in Development and Disease
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commitment is a general function of Cut
Ct is expressed in many different cell and tissue types [14], thus
we tested the Ct switch function in diverse developmental contexts.
Ct activity was eliminated in the Drosophila eye using RNAi
(Figure 3C, 3G), resulting in an overall reduction of the eye size
(Figure 4A, 4B), and a loss of interommatidial bristles (Figure 3A,
3E), which normally express Ct (Figure 3C). Consistently,
expression of the bristle shaft progenitor marker DE-Cadherin
[15] was lost in GMR::ct
RNAi pupal retinas (Figure 3B, 3F).
Figure 1. Cut directly represses rpr and apoptosis in the PS primordium. (A) Posterior spiracle (PS) of a 1
st instar wild-type Drosophila larva.
The filzko ¨rper is highlighted by red asterisks. (B, C) rpr mRNA (green) expression in stage 11 wild-type (B) and ct mutant (C) embryos. Spalt (Sal)
protein (blue) labels stigmatophore precursor cells, Cut (Ct) protein (red, nuclear) marks spiracular chamber and filzko ¨rper precursor cells and the
apical membrane marker Crb (red) outlines the cells. Small, green arrows in (C) mark rpr positive spiracular chamber and filzko ¨rper precursor cells in
the eighth abdominal segment (A8) of ct mutant embryos. (D, E) Over-expression of the apoptosis sensor UAS-Apoliner using the arm-GAL4 driver in
stage 11 wild-type (D) and ct mutant (E) embryos. Small, green arrows in (E) mark apoptotic cells in PS precursor cells (A8) of ct mutant embryos. (F, G)
TUNEL stainings in wild-type (F) and ct mutant (G) embryos. Closed arrowhead in (G) marks TUNEL-positive cells in ct mutants, which are absent in
wild-type embryos (F). (H, I) Co-localization of GFP protein and rpr mRNA (H) or Cut protein (I) in stage 15 rpr-HRE-571 embryos. White circles mark the
PS primordium. (J) Top: conservation blot of rpr-HRE-571 genomic region obtained from the UCSC genome browser (http://genome.ucsc.edu/).
Species used for generating blot are also shown in Figure S2A. Bottom: diagram of the rpr-HRE-571 deletion constructs tested. (K) EMSA using S2 sub-
fragment with Ct binding sites either in wild-type (wt probe) or mutated (mut. probe) version and no protein (2), purified MBP protein (M), and
purified Cut-MBP fusion protein consisting of the Cut repeat 3 and the Cut homeodomain (C). The black arrowheads indicate the specific DNA-protein
complexes. Loading of equal amounts of labeled wild-type and mutated oligonucleotides is illustrated by formation of comparable amounts of
unspecific DNA-protein complexes (black arrow). (L–O) Reporter gene expression in the PS of stage 15 embryos driven by the fragments described
above. In the S2-Ctbs-GFP, line Ct binding sites within the rpr-HRE-571-S2 fragment are mutated. Spalt (Sal) and Cut (Ct) proteins label stigmatophore
(blue) or spiracular chamber and filzko ¨rper cells (red). Closed, yellow arrowheads in (N) and (M) mark reporter gene expression in filzko ¨rper cells,
whereas open, yellow arrowheads in (L) and (M) mark missing GFP expression.
doi:10.1371/journal.pgen.1002582.g001
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significantly increased in eye discs of ey::ct
RNAi 3
rd instar larvae
(Figure 3D, 3H), and a significant induction of rpr RNA levels was
observed using quantitative Real Time-PCR (qRT-PCR)
(Figure 3K). Co-expression of either the apoptosis inhibitor p35,
which rescues the eye size (Figure 4C), or of a rpr
RNAi construct
along with the ct
RNAi transgene resulted in a survival of ct deficient
cells, as evidenced by the expression of the bristle shaft progenitor
maker DE-Cadherin (Figure 3J). However, reminiscent to the
phenotypes in the PS (Figure 2E, 2J9), these cells were unable to
adopt their terminal fate due to the absence of the cell-
specification factor Ct, and consequently fully differentiated
interommatidial bristles were absent (Figure 3I). Similar results
were obtained in other cell types specified by Ct (Figure S6),
suggesting that the Ct-dependent switch between cell-type
specification and programmed cell death is of general relevance.
Simultaneous and antagonistic regulation of
differentiation and apoptosis represents a cancer
prevention mechanism
By analyzing the Ct-rpr interaction in two well-established in vivo
Drosophila cancer models, we asked whether the combined
transcriptional regulation of differentiation and apoptosis repres-
sion by Ct could represent a cancer prevention mechanism. In the
oncogenic ‘‘eyeful’’ model [16], eye tumors occurred in 72.5% of
control flies, with 4.9% of them showing macroscopically visible
secondary tumor growths derived from the developing retina
(Figure 4H, 4N) due to the eye-specific over-expression of the
Notch ligand Delta (Dl) and the two epigenetic regulators
longitudinals lacking (lola) and pipsqueak (psq) [16]. In contrast, pre-
oncogenic ey::Dl flies over-expressing Dl exclusively in eye tissue
[16] never displayed any eye tumors or invasive tumors but only
mildly overgrown eyes (Figure 4D, 4N). Eye-specific inhibition of
Ct activity alone only caused a small increase in primary and
secondary tumor incidences in both sensitized backgrounds
(Figure 4E, 4I, 4N), however, these numbers were dramatically
increased when Ct function and the ability to activate apoptosis
were simultaneously inhibited (Figure 4F, 4G, 4K, 4L, 4M, 4N).
Consistently, increased numbers of apoptotic cells were found in
tumorous tissue with reduced Ct levels (ey::Dl;2xct
RNAi) (Figure 4P,
4Q), demonstrating that the coupled regulation of differentiation
and apoptosis by a single transcription factor is an important
mechanism to suppress cancer.
However, despite increased apoptosis activation in ey::Dl;2xct
RNAi
eye imaginal discs (Figure 4P), which should result in a reduction of
tumor growth, tumor formation in these animals was increased
(Figure 4N, 4Q). Using the proliferation marker Phosphorylated
histone H3 (PH3), we could demonstrate that the tumor growth
induced by differentiation loss is due to excessive cell proliferation
(Figure 4P), which is in line with previous results [4]. What is the
molecular basis for this phenotype? RT-PCR analysis of candidate
genes involved in cell cycle and growth control using ey::Dl and
ey::Dl;ct
RNAi eye imaginal discs revealed a strong induction of
phosphoinositide 3-kinase (PI3K) upon Ct depletion (Figure 4O). It
Figure 2. Cut-dependent repression of apoptosis is required for cell survival and differentiation. (A–E) Cuticle preparations of the
different genotypes with focus on the PS of 1
st instar Drosophila larvae. Closed, orange arrowheads in (A) and (B) mark the filzko ¨rper, whereas open,
orange arrowheads in (C, D and E) indicate the absence of this structure in the respective genotypes. (F–L) Labeling of the different parts of the PS
primordium of stage 15 embryos in the different genetic backgrounds using the filzko ¨rper marker Ct (red, nuclear), the stigmatophore marker Sal
(blue) and the apical membrane marker Crb (red). In (G, I, J, K and L) GFP expression (green) driven by the ems-GAL4 driver is shown in the different
genetic backgrounds. Red asterisks in (F9–J9) mark the invaginated cells of the future filzko ¨rper. Closed, yellow circles in (F) and (G) mark Ct-positive,
invaginated filzko ¨rper precursor cells, dashed yellow circle in (H) indicates the absence of these cells. Dashed, light blue circle in (I) highlights the
absence of GFP-positive cells, whereas closed, light blue circle in (J) mark the presence of these cells. Note that some cells expressing GFP under the
control of the ems-GAL4 driver invaginate deeper than the Ct expressing cells, thus they are still present in ct
db7 mutant embryos, indicated by closed,
green arrowheads in (K) and (L). Closed, yellow arrowhead in (K) marks Ct and GFP-positive cells in ems::GFP embryos. Open, yellow arrowhead in (L)
highlights the absence of these cells in ct mutant embryos. In (A) to (J9) lateral views, in (K) and (L) dorsal views of embryos are shown.
doi:10.1371/journal.pgen.1002582.g002
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oncogenicbackground leadstotumorformation[17] andthat PI3K
is a limiting factor for Ras
V12 Dlg
RNAi induced tumor growth [18].
Thus we tested its contribution to tumor formation in Ct-induced
oncogenic eyes by reducing its level in ey::Dl;2xct
RNAi animals.
Interestingly, we not only found a rescue of the tumorous eye
growth, but also a dramatic increase in the occurrence of smaller
eyes in ey::Dl;2xct
RNAi;PI3K
RNAi animals (Figure 4Q), which is similar
to the apoptosis-induced ‘‘small eye’’ phenotype observed upon Ct
depletion in the wild-type background (Figure 4B). Taken together,
these results show that the Ct-dependent tumor growth is in part
mediated by the up-regulation of the PI3K signaling pathway and
that this pro-tumorigenic effect counteracts the anti-tumorigenic
apoptosis effect of Ct.
Cell adhesive properties are critical for migratory
behavior of tumor cells
We found cell clusters expressing the eye differentiation marker
ELAV at abnormal, ectopic positions in undifferentiated tissue of
3
rd instar eye-antennal discs (Figure S7), and it had been shown
before that changes in the adhesive properties of cells are critical in
inducing migratory behavior [19,20]. Consistently, transcriptome
profiling experiments revealed a reduction in the expression of cell
adhesion genes in eye-imaginal discs of Ct depleted animals
exhibiting primary and secondary tumor formation (ey::Dl;2xct
RNAi)
in comparison to control animals (ey::Dl) (Figure 5A). To test the
significance of this finding, we interfered with the function of a-
PS4 integrin, one of the genes identified as Ct responsive
(Figure 5A), by reducing its expression and the expression of its
heterodimeric interaction partner b-PS integrin (mys) [21] in the
ey::Dl pre-oncogenic background. We observed an increase in
primary and secondary tumor formation in both situations, while
reducing the activity of a related but Ct-independent integrin, the
a-PS2 integrin (if), did not have any effect (Figure 5B). Since
decreasing the activity of another Ct responsive cell adhesion gene,
namely Tissue inhibitor of metalloproteases (Timp), also induced an
increase in secondary tumors (Figure 5B), we asked if restoration of
cell adhesion would be able to rescue this phenotype in the Ct loss-
of-function setting. To this end, we expressed one of the major
adhesion genes regulated by Ct, DE-Cad (Figure 5C), in eye cells of
eyeful+ct
RNAi;p35 animals, which display high rates of invasive
tumors (Figure 4N, Figure 5D), and observed a reduction of
secondary tumor growth rate by more than 50% (Figure 5D).
These results demonstrate that regulation of cell adhesiveness is
one of the essential Ct-dependent mechanisms to suppress tumor
spread. In vertebrates, invasive tumor growth requires the
detachment of abnormal cells from tumor tissue and their
circulation in the bloodstream [22]. To test if secondary tumor
formation mediated by loss of Ct function is dependent on a
similar mechanism, we analyzed the hemolymph, the insect
Figure 3. General function of Ct in apoptosis repression and induction of differentiation. (A, E, I) Scanning electron micrographs of
individual ommatidia of adult Drosophila fly eyes with indicated genotypes are shown. The closed, red arrowheads in (A) mark interommatidial
bristles, the open, red arrowheads in (E) mark the absence of these structures. The closed, light red arrowheads in (I) indicate the presence of tissue
that would normally develop into interommatidial bristles. (B, F, J) Projections of consecutive confocal sections of one ommatidium of 50 h pupal
retinas labeled with DE-Cadherin. Interommatidial bristles are marked by red, closed arrowheads in (B). Open arrowheads in (F) mark absence of DE-
Cad, light-red arrowheads in (J) mark reduced DE-Cadherin levels in shaft cells of interommatidial bristles. (C, G) Projections of consecutive confocal
sections of one ommatidium of 50 h pupal retinas of GMR::lacZ control (C) and GMR::ct
RNAi flies (G). (D, H) Expression of the apoptosis marker Caspase-
3 (Casp-3) in 3
rd instar eye-antennal discs of control Dcr2; ey::lacZ (D) and Dcr2; ey::2xct
RNAi (H) animals. Yellow asterisks in (H) mark Casp-3 positive
cells in Dcr2; ey::2xct
RNAi eye imaginal discs. (K) Relative mRNA expression levels of rpr, grim, Wrinkled (W) and sickle (skl)i n3
rd instar eye-antennal discs
of control Dcr2; ey::lacZ and Dcr2; ey::2xct
RNAi animals.
doi:10.1371/journal.pgen.1002582.g003
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PLoS Genetics | www.plosgenetics.org 5 March 2012 | Volume 8 | Issue 3 | e1002582Figure 4. The Ct switch function represents a cancer prevention mechanism. (A–M) Adult compound eyes of the respective genotypes are
shown. (L) eyeful::ct
RNAi; p35 flies show high frequency of long range metastasis (marked by yellow arrowhead), a close-up of which is shown in (M).
Eyes of such eyeful::ct
RNAi; p35 flies show undifferentiated and overproliferated eye tissue (marked by light blue arrowhead). (N) Quantification of
primary and secondary tumor formation in different genetic backgrounds. (O) Relative transcript levels of selected genes involved in cell cycle
control, DNA damage response, growth control and epigenetic regulation in eye-antennal discs of 3
rd instar larvae of pre-oncogenic control animals
(ey::Dl) and animals with reduced Ct activity (ey::Dl;2xct
RNAi). (P) Expression of the apoptosis marker Caspase-3 (Casp-3) and the proliferation marker
Phosphorylated histone H3 (PH3) in representative 3
rd instar eye-antennal discs of ey::Dl and ey::Dl;2xct
RNAi animals. An increase in Casp-3 and PH3
positive cells is seen in the area below the dashed, yellow line highlighting the morphogenetic furrow. (Q) Top panel: representative pictures of eyes
from ey::Dl;PI3K
RNAi and ey::Dl;2xct
RNAi;PI3K
RNAi animals. Bottom panel: quantification of tumorous eye growth, secondary tumor growth and ‘‘small
eye’’ phenotype in ey::Dl;2xct
RNAi and ey::Dl;2xct
RNAi;PI3K
RNAi and ey::Dl;PI3K
RNAi animals.
doi:10.1371/journal.pgen.1002582.g004
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increase in GFP-labeled eye-imaginal disc cells in the hemolymph
of animals forming invasive tumors (eyeful+GFP;ct
RNAi;p35)i n
comparison to control animals (ey::GFP) (Figure 5E, 5F), suggesting
that tumor cells in flies indeed circulate through the bloodstream
and invade ectopic locations. In sum, these results demonstrate
that transcriptional coupling of differentiation and apoptosis is a
cell-intrinsic mechanism to ensure normal development and to
prevent tumor initiation, progression and invasion, which is at
least in part achieved by fine-tuning the adhesive properties of cells
required for tissue integrity.
Antagonistic coupling of cell fate commitment and
apoptosis is a general and evolutionary conserved cancer
prevention mechanism
We next explored whether the effective regulation of pro-
grammed cell death by Ct has been conserved during evolution.
The vertebrate homologue of Cut, Cux1, has a well-documented
function in cell differentiation during normal development as well
as in tumor initiation and progression in specific cancer types [23].
In addition, several studies show that Cux1 represses apoptosis
during normal vertebrate development [24,25,26], and just
recently it has been demonstrated that Cux1 knock-down leads
to activated apoptosis and to reduced growth of xenograft tumors
in vivo [25,27]. To further investigate the mechanistic basis of Cux1
function in mediating apoptosis repression in vertebrates, we
suppressed Cux1 in Panc1 pancreatic cancer cells (Figure 6A) and
determined the transcriptional response of human apoptosis genes.
Strikingly, mRNA levels of the pro-apoptotic gene puma were
consistently elevated, whereas the anti-apoptotic gene Bcl-2 was
down-regulated upon Cux1 depletion (Figure 6A). Since BH3-only
proteins, like Puma, and Bcl-2 are important for the release of the
vertebrate functional equivalent of Rpr, Smac/DIABLO, from
mitochondria [28] and since Cux1 binding sites are present close
to the puma coding region (Table S1), these results suggest that the
regulatory wiring of differentiation and apoptosis, at the level of
Cut, is functionally conserved in vertebrates.
Does this regulatory layout represent a general mechanism
employed by other differentiation factors? This would require a
whole suite of cell-type specifying transcription factors to repress
cell death genes by interacting with distinct enhancer modules
located in their regulatory regions. In addition, these modules
should follow a similar functional logic to the rpr-HRE-571
enhancer, in that cell-type specific gene activation is counteracted
by strong repressing inputs from linked cis-elements (Figure 1L–
1O). In line with this, we found that a different conserved
enhancer module on the Drosophila rpr regulatory region (rpr-HRE-
707) drove expression in CNS midline cells of stage 14 embryos
(Figure 6F), which never express rpr at this and subsequent
developmental stages (Figure 6L) [29]. However, extending the
enhancer to include additional cis-elements (rpr-HRE-707+156)
(Figure 6D) resulted in loss of enhancer activity (Figure 6H). Using
the JASPAR database [30], we found consensus binding sequences
for POU-domain containing transcription factors on the extended
enhancer module, and one of these factors, Ventral veins lacking
(Vvl), is known to function in midline glial cells and to repress
apoptosis [31,32]. Our analysis revealed a partial overlap of Vvl
and reporter gene expression in rpr-HRE-707 embryos (Figure 6J),
and consistently ectopic rpr transcripts were detected in several
midline cells of vvl mutants (Figure 6L, 6M). Due to the existence
of GFP-positive cells not expressing Vvl (Figure 6J), we assume
that not only Vvl but also other POU transcription factors interact
with the rpr-HRE-707+156 enhancer to repress rpr transcription in
midline cells. Revisiting the rpr-HRE-571 enhancer module
revealed that extension of the enhancer also led to a complete
loss of reporter activity (compare Figure 1L, Figure 6E, 6G). Thus,
complete repression of rpr transcription in the PS requires two
inhibitory inputs: one active in filzko ¨rper cells, which we had
identified to be mediated by Ct, and one so-far unknown repressor
functional in stigmatophore cells. Importantly, the functional
analogy of Vvl and Ct also extended to the tumor suppression
activity, since, like in the case of Ct (Figure 4N), primary and
secondary tumor frequencies were increased when the ability to
activate apoptosis and Vvl function was impaired at the same time
(Figure 6K). Furthermore, we identified two unrelated cell-type
specifying transcription factors in addition to Ct and Vvl, which
showed similar behavior with regards to tumor suppression (Figure
S8). Together with the fact that the regulatory sequences flanking
the Drosophila rpr coding region show significantly less sequence
divergence than expected and a high occurrence of conserved
transcription factor binding motifs (Figure 6B, 6C), these findings
lead us to propose that coupling of differentiation and cell death
repression via a single transcription factor represents a general
cancer prevention mechanism (Figure 7), which could be
employed by a large number of developmental regulators in
diverse organisms.
Discussion
Programmed cell death is an integral aspect of animal
development [33]. Genetic studies in C. elegans, Drosophila and
mouse have shown that apoptosis is used to sculpt tissues and to
remove excessive and unwanted cells, thus defining the
morphology required for diverse physiological functions [34]. In
this context, apoptosis is usually regulated by cell signaling
pathways [33,35,36]. In addition to its role in tissue morpho-
genesis, apoptosis is also required to eliminate potentially
deleterious cells, which in most cases involves complex multi-
step control mechanisms [33,37]. One such situation generating
harmful cells is the inability to differentiate or adopt the
Figure 5. Invasive tumor growth induced by Ct depletion is due to changes in adhesive cell properties. (A) Changes in expression of cell
adhesion genes in 3
rd instar eye-antennal imaginal discs of ey::Dl;2xct
RNAi versus ey::Dl animals identified by expression profiling experiments. Red
arrows indicate reduced expression, green arrow induced expression of the respective genes in ey::Dl;2xct
RNAi animals. (B) Top: Representative
pictures of tumor growth in ey::Dl;bPSintegrin
RNAi and ey::Dl;aPS4integrin
RNAi flies. Green arrowhead marks secondary tumor growth in the abdomen.
Bottom: Quantification of primary and secondary tumor growth in ey::Dl;aPS4integrin
RNAi, ey::Dl;bPSintegrin
RNAi, ey::Dl;aPS2integrin
RNAi and
ey::Dl;Timp
RNAi flies. (C) Relative transcript levels of DE-Cad, Cad86C and Cad99C in eye-antennal discs of 3
rd instar larvae of control animals (Dcr2;
ey::lacZ) and in animals with reduced Ct activity (Dcr2; ey::2xct
RNAi). (D) Quantification of secondary tumor growth rates in different genetic
backgrounds. Co-expression of E-Cad strongly reduces invasive tumor growth rates in eyeful+ct
RNAi;p35 flies. (E) Schematic drawing of a 3
rd instar larva
expressing GFP in eye-imaginal discs (either ey::GFP or eyeful+GFP;ct
RNAi;p35). Locations of GFP-labeled eye-imaginal discs and the insect circulatory
fluid, the hemolymph, are indicated by arrows. For analysis of the hemolymph, the insect circulatory fluid is extracted by bleeding out the larvae after
cutting at the posterior end (indicated by dashed, blue line). (F) Left: Quantification of GFP-positive cells in the hemolymph of wild-type, ey::GFP and
eyeful+GFP;ct
RNAi;p35 3
rd instar larvae. Right: Relative GFP transcript levels in the hemolymph of ey::GFP and eyeful+GFP;ct
RNAi;p35 3
rd instar larvae.
doi:10.1371/journal.pgen.1002582.g005
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proliferation and cancer development, and thus requires the
immediate killing of these cells. However, even though it is
established that apoptosis is a protective mechanism against
tumorigenesis in cases of aberrant cell differentiation [1,34,38],
the interplay of the two processes at the mechanistic level has
remained unclear. In our study, we show that the simultaneous
and antagonistic regulation of differentiation and apoptosis is a
hard-wired developmental program and carried out by individual
transcription factors, such as Cut. Our results demonstrate that
impairment of differentiation in the cell lineage specified by Cut
instantaneously triggers locally restricted apoptosis by releasing
transcriptional repression of the pro-apoptotic gene rpr in these
cells. Due to its immediate effect, the coupling of differentiation
and apoptosis on the transcriptional level represents one of the
fastest and most direct mechanisms to eliminate abnormal cells in
status nascendi and thereby immediately interferes with their
potential to develop into harmful cells.
Figure 6. Functional and evolutionary conservation of coupling differentiation and apoptosis on the transcription factor level. (A)
Relative mRNA expression of eight apoptosis genes after lenti-virus transduced stable Cux1 (p200) knock-down in human Panc1 cancer cells. RT-PCRs
are shown for two independent Cux1 knock-down lines, KDa in blue and KDb in red. Results are shown as the expression ratios between shCux1/shC-
treated cells and are representative for three independent experiments. Western blot shows knock-down efficiencies in both independent stable
Cux1 (p200) knock-down lines (KDa, KDb) and Cux1 expression in an shRNA control knock-down. Stronger effects of KDa (reduced) versus KDb
(almost complete) p200 Cux1 knock-down on target gene expression is very likely due to the processed p110 Cux1 isoform, which can have opposite
transcriptional effects to the p200 full-length form [62]. (B, C) Distribution of average conservation (B) and average number of conserved DNA binding
motifs per 1000 bp (C) in all non-coding regions of the D. melanogaster genome. The red bars highlight the rpr intergenic regions, showing that 93%
of all D. melanogaster non-coding regions are less conserved (B) and 89% of all non-coding regions have fewer conserved DNA binding sites per
1000 bp (C) compared to the rpr intergenic regions. (D) Conservation graph of the sequence located downstream of the rpr coding region obtained
from the UCSC genome browser (http://genome.ucsc.edu/). The following regulatory regions tested are marked in different colors: rpr-HRE-571 (light-
red), rpr-HRE-571+210 (dark-red), rpr-HRE-707 (light-blue) and rpr-HRE-707+156 (dark-blue). (E–H) Reporter gene expression driven by the fragments
described above. The rpr-HRE-571 enhancer drives reporter gene expression in the PS (E), which is abolished in the rpr-HRE-571+210 reporter line (G).
Similarly, reporter gene expression in CNS midline cells in the rpr-HRE-707 line (F) is completely suppressed in the rpr-HRE-707+156 transgenic line
(H). Closed, yellow arrowheads in (E) and (F) mark presence of reporter gene expression, whereas open, yellow arrowheads in (G) and (H) mark
absence of GFP expression. (I, J) Co-localization of GFP with Sal in the rpr-HRE-571 (I) and with Vvl in the rpr-HRE-707 (J) reporter lines. (K)
Quantification of primary and secondary tumor formation in different genetic backgrounds. Only when Vvl function is reduced and apoptosis is
simultaneously inhibited, tumors and metastasis develop. (L, M) rpr transcripts are not found in CNS midline cells of stage 14 wild-type embryos (L)
but in vvl mutants (M).
doi:10.1371/journal.pgen.1002582.g006
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cell-type specification is not only mediated by the cell death
promoting gene rpr but also by hid [8]. However, despite the same
trigger, which is the inability to properly differentiate, the
transcriptional basis for inducing the expression of one of these
two apoptosis genes seems to be quite different: in Drosophila early
developmental mutants only the expression of the pro-apoptotic
gene hid is up-regulated [8], whereas our study shows that
exclusively the transcription of rpr is induced when a factor
specifying a distinct cell type is lost. Although it is currently
unknown how hid expression is regulated at the transcriptional
level, this raises the possibility that the apoptosis gene hid acts a
safeguard when broad positional information at the onset of
embryogenesis is absent, whereas rpr might take over this function
later in development when individual and specific cell types are
defined by transcription factors restricting cell fate choices.
Given the well-known role of the vertebrate homologue of Cut,
Cux1, in tumor initiation and progression in specific cancer types
[23], we addressed whether the switch function of the cell
specification factor Cut is also relevant in a pathological context.
We found that simultaneous inhibition of Cut function and
apoptosis within a sensitized background increases tumor
formation and metastasis to secondary sites in the animal. In
contrast, down-regulation of Cut and inhibition of apoptosis in a
normal developmental context, such as in the Drosophila PS or the
developing eye, only results in the survival of the Cut deprived
cells, but not in tumor development. These results demonstrate
that cells, which are unable to undergo the cell lineage-specific
differentiation program, have to be eliminated, since they have the
potential to develop into cancerous cells when other genetic or
micro-environmental changes accumulate [19,27,39]. But why do
differentiation-deprived cells form tumors in a cancer-prone tissue
environment despite the ability to activate the apoptotic rescue
pathway? This is due to the fact that the transcription factor Cut,
as part of its selector gene function, coordinately regulates multiple
cellular processes, including differentiation, apoptosis, cell adhe-
sion, but also proliferation, which are all required for proper cell
fate specification and the maintenance of a differentiated state
(thereby preventing tumor formation). If, however, Cut activity is
abolished, all its downstream functions are affected, leading not
only to the activation of apoptosis, but also to reduced
differentiation and adhesion properties and the activation of cell
proliferation, which is, in the case of Cut, mediated (at least in
part) by the PI3K signaling pathway. Thus, loss of Cut function
stimulates tumor growth in a sensitized background, since the pro-
tumorigenic effects of deregulated proliferation and cell adhesive-
ness out-compete the anti-tumorigenic apoptosis effects at work.
However, when the anti-tumorigenic effect is eliminated in the
differentiation-compromised cancer tissue, tumorigenesis is strong-
ly enhanced, which resembles a prevalent situation in aggressive
human cancers characterized by the loss of differentiation, the
resistance to apoptosis activation and the mis-regulation of
adhesion properties [1,40,41].
Several lines of evidence suggest that the dual role of Cut in
differentiation and apoptosis for cancer prevention is conserved in
evolution. First of all, the two vertebrate homologues of Cut, Cux1
and Cux2, code for homeobox-containing transcription factors,
which are crucially involved in cell-type specific terminal differen-
tiation [14,23,42]. Both, Cux1 and Cux2, have similar binding
specificities to Drosophila Cut [43], they also operate as transcrip-
Figure 7. Model of cancer prevention mechanism by cell fate specifying transcription factors like Cut. (A) During normal development,
cell-type specification factors like Cut ensure the survival of cells by repressing apoptosis while at the same time these factors also induce a specific
differentiation program, which generates cells with a specific terminal cell fate. (B) In the case of a mutation in a cell-type specification factor those
cells unable to differentiate, which are potentially harmful to the organism, are removed by releasing apoptosis repression conferred by the same
cell-type specification factor. Thus, the transcriptional coupling of differentiation and apoptosis regulation represents a very fast and efficient cancer
prevention mechanism. (C) Together with other mutations creating a sensitized background, like the over-activation of the Notch (N) signaling
pathway, cells that acquire the inability to differentiate and a resistance to apoptosis activation, two important hallmarks of cancer [1,2], very easily
develop into cancer cells.
doi:10.1371/journal.pgen.1002582.g007
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tiation pathways [26] and, like Drosophila Cut, they act as
downstream effectors of the Notch signaling pathway [44,45]. In
addition to their well-established role in development and
differentiation,therearealso several exampleslinking thevertebrate
Cut homologue Cux1 to apoptosis and cancer. First, inhibition or
partial disruption of Cux1 function in mice leads to increased
apoptosis rates in vivo [24,26]. Second, Cux1 regulates normal
hematopoiesis, in part by modulating the levels of survival and
apoptosis factors [26].Third, Cux1 plays a prominentrolein cancer
progression [23]. And fourth, induced down-regulation of Cux1 in
subcutaneous xenograft tumors leads to activation of apoptosis and
to reduced tumor growth [25]. Our results now show that the Cut-
Rpr regulatory wiring of apoptosis and differentiation is conserved
in vertebrates. In mammalian cells, the Rpr functional homologue,
Smac/DIABLO, which is normally compartmentalized within
mitochondria, has to be released to execute its pro-apoptotic
function by binding to and inactivating Inhibitors of Apoptosis
(IAPs) [46]. This process requires the permeabilization of the outer
mitochondrial membrane (MOMP), which is achieved by the
interaction of pro-apoptotic proteins like Puma with anti-apoptotic
proteins like Bcl-2, which normally inhibit MOMP [47]. We now
show that down-regulation of Cux1 in pancreatic cancer cell lines
leads specifically to the transcriptional induction of the pro-
apoptotic gene puma and the down-regulation of the anti-apoptotic
gene Bcl-2. Thus, two crucial regulators for Smac/DIABLO release
arecontrolled byCux1on the transcriptional level,showingthat the
basic design principle of the Cut-Rpr regulatory wiring is conserved
but has been adapted to the system requirements in evolution. In
future, it will be intriguing to study this mechanism in diverse
cellular backgrounds, including stem cells, which neither die nor
differentiate.
Materials and Methods
Bioinformatics
To identify Abd-B binding sites we used the method of
Wasserman and Sandelin (2004) [48] with the Abd-B Position
Frequency Matrix [49] (http://jaspar.genereg.net/) and 90% cut-
off. Abd-B binding site clusters were identified if at least three Abd-
B sites were present in a 400 bp window. Conserved enhancers
were identified using PhastCon score [50]. Within conserved
regions, Ct binding sites were identified using published sequence
data [49]. Vvl and Cux1 binding sites were identified using the Vvl
and Cux1 Position Frequency Matrices available at the JASPAR
database [49] (http://jaspar.genereg.net/).
Genetics
Drosophila melanogaster strain Oregon R was used as wild type.
Amorphic allele ct
db7/FM7 [51], ems-Gal4 and ems-Gal4, UAS-GFP/
TM6B [13] were obtained from J. Castelli-Gair Hombria, UAS-
Dcr2; ey-Gal4 from B. Dickson, eq-Gal4/TM6B [52] from H. Pi,
UAS-Apoliner5 [11] from J. P. Vincent, UAS-ct
EHK2/CyO [53], UAS-
ct
RNAi; UAS-ct
RNAi (Grueber and Jan, unpublished) from Y.N. Jan
and ey-Gal4, UAS-Dl/CyO and eyeful flies (ey-Gal4, GS88A8, UAS-
Dl/CyO) from M. Domiguez [16]. UAS-Dcr2; C96-Gal4 (BL-
25757), UAS-CD8::GFP (BL-5130) from Bloomington stock center.
GMR-Gal4, UAS-p35, UAS-Abd-B, arm-Gal4, UAS-rpr, UAS-lacZ
were described elsewhere [54,55,56,57]. Other UAS-RNAi lines
were obtained either from BDSC, VDRC or TRiP: DE-Cad
(v8024), rpr (v12045), vvl (JF02126), gro (v6316), H (v24466), aPS2
(if) (BL27544), aPS4 (v109783), bPS (mys) (HMS00043), PI3K
(v107390) and Timp (v109427). Five independent transgenic lines
were analyzed for each reporter construct.
Mammalian cell culture and lentivirus-mediated Cux1
knock-down
Panc-1 human pancreatic cancer cells (Department of Surgery,
Medical Faculty, University of Heidelberg) and 293 T cells were
maintained in DMEM supplemented with 10% fetal bovine
serum, 2 mM L-glutamine, non-essential amino acids, 100 U/ml
penicillin, 100 U/ml streptomycin, and 0.25 mg/ml amphotericin
B. shRNA directed against human Cux1 was generated using the
following complementary oligonucleotides (forward and reverse):
Cux1_KDa:
59CCGGAAGAAGAACACTCCAGAGGATCTCGAGATC-
CTCTGGAGTGTTCTTCTTTTTTTG39 and
59AATTCAAAAAAAGAAGAACACTCCAGAGGATCTCG-
AGATCCTCTGGAGTGTTCTTCTT39;
Cux1_KDb:
59CCGGAAGAATCTTCTCGTTTGAAACCTCGAGGTT-
TCAAACGAGAAGATTCTTTTTTTG39 and
59AATTCAAAAAAAGAATCTTCTCGTTTGAAACCTCG-
AGGTTTCAAACGAGAAGATTCTT39;
shRNA control (C),
59CCGGAATTGCCAGCTGGTTCCATCACTCGAGTGA-
TGGAACCAGCTGGCAATTTTTTTG39 and
59CCGGAATTGCCAGCTGGTTCCATCACTCGAGTGA-
TGGAACCAGCTGGCAATTTTTTTG39.
pLKO lentiviral vectors containing shRNA were transfected
into 293 T cells together with psPAX2 (packaging vector) and
pMD2.G (VSV-G envelope protein expression vector) using the
calcium-phosphate transfection kit (Sigma). Panc-1 cells were
infected using lentivirus-containing 293 T cell supernatant and
Cux1 protein levels were assessed by Western blotting using anti-
Cux1 (Sigma-Aldrich) and anti-b-Actin (GeneTex) antibodies.
Plasmid constructs
All enhancer fragments were PCR amplified from genomic
DNA and cloned in pHPelican-GFP [58] or pHPelican-GFP_DEST
[59]. For binding site mutations, a two-step overlap PCR was
performed. For mutating Ct binding sites within the rpr-HRE-571-
S2 enhancer fragment, mutation introduced into the Cut
consensus sequences were identical to the ones introduced into
the EMSA probes (see below). Primer sequences are available
upon request.
Real-time PCR
Real Time PCR was performed following standard protocols
using SYBR green. Expression was normalized to GAPDH for
mammalian cells and to endogenous actin5C mRNA for imaginal
disc analysis. Relative expression levels are based on three
biological replicates.
Histology and scanning electron microscopy
Drosophila embryos were fixed as described [56]. Eye discs or
wing discs were dissected in PBS and fixed in 4% paraformalde-
hyde/PBS for 10 min for immunostaining. In situ hybridization
and immunochemistry were performed as described [56].
Fluorescent mRNA/protein double labeling and fluorescent
duplex in situ hybridizations were done as described previously
[60]. Primary Antibodies used were: mouse anti-Ct 2B10 (1:200,
DSHB), mouse anti-Crb cq4 (1:200, DSHB), rat anti-DE-Cad
DCAD2 (1:100, DSHB), mouse anti-ELAV (1:200, DSHB), rat
anti-Sal (1:800 kind gift from R. Barrio), rabbit anti-PH3 (1:200,
Santa Cruz), rabbit anti-Cleaved Caspase-3 (1:50 Cell Signalling),
mouse anti-GFP (1:1000, Roche), rabbit anti-GFP (1:2000,
Sigma), anti-DIG POD (1:200, Roche), Streptavidin HRP
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Orange staining and cuticle preparation were carried out as
described in Lohmann et al. (2002) [55] and Zhai et al. (2010)
[61]. TUNEL assay was performed with the In Situ Cell Death
Detection Kit (TMR) from Roche according to the manufacturer’s
instruction.
Protein purfication and electrophoretic mobility shift
assays (EMSA)
Cut CR3HD (4849–5412 of ctRA from Y.N. Jan) was cloned
into pMAL2-c2x vector (NEB) and expressed as Maltose Binding
Protein (MBP) fusion proteins. EMSAs were carried out as
described in Sto ¨be et al. (2009) [56]. The following oligonucleo-
tides (S2 subfragment) were used for analyzing the Cut binding
sequence in EMSA (only forward strand is shown):
Wild-type. 59GCACTTTTGCCTGCAGTTCAACTCGG-
TTCAGTTCGGTTGTGTCATAAAAAATC39
Mutated. 59GCACTTTTGCCTGCAGTGGAACTCGGT-
GGAGTGGGGTTGTGTCATAAAAAATC39
Cut consensus sequences are underlined, exchanged nucleotides
in the mutated versus the wild-type sequence are shown in bold.
Quantification of GFP labeled eye cells in hemolymph of
3
rd instar larvae
ey::CD8-GFP or eyeful+CD8-GFP;ct
RNAi;p35 3
rd instar larvae
were dissected by rupturing the larval cuticle at the posterior end
with a pair of fine forceps, the hemolymph was collected in ice-
cold Schneider’s medium (Invitrogen GIBCO) containing 16
Complete protease inhibitor mixture (Roche). Hemolymph cells
were analyzed via FACSAria to quantify GFP-labeled cells
circulating within the hemolymph. In addition, GFP mRNA levels
within the hemolymph were measured by qRT-PCR.
Microarray
Eye-antennal discs of ey::Dl or ey::Dl::2xct
RNAi 3
rd instar larvae
were dissected in cold PBS, total RNA was extracted using
standard procedures. Microarray analysis was conducted at the
Genomics Core Facility, EMBL, Heidelberg, Germany. Micro-
array data analysis was performed using the R package as
described previously [54].
Supporting Information
Figure S1 Cut directly represses rpr transcription in a cell-
autonomous manner. (A–D) Expression of the posterior spiracle
markers Spalt (Sal) (green), which labels the stigmatophore
precursor cells, and Cut (Ct) (red), which marks the spiracular
chamber and filzko ¨rper precursor cells, in stage 11 (A), stage 13
(B), stage 14 (C) and stage 16 (D) embryos. In (A), (B) and (D)
lateral views of the posterior spiracle primordia are shown,
whereas in (C) a dorsal view is presented. (E, F) rpr mRNA
expression (green) in posterior spiracle primordia of stage 14 wild-
type (E) and ct mutant (F) embryos is shown (lateral view). Spalt
(Sal) protein (blue) labels stigmatophore precursor cells, Cut (Ct)
protein (red, nuclear) marks spiracular chamber and filzko ¨rper
precursor cells and the apical membrane marker Crb (red) outlines
the cells. Small, white arrow in (F) marks additional tracheal cells
found at the posterior end in ct mutant embryos; yellow circle in (F)
highlights rpr expression in ct mutant embryos. (G) EMSA using S2
sub-fragment with Ct binding sites either in wild-type (wt probe) or
mutated (mut. probe) version and no protein (2), purified MBP
protein (M), and purified Cut-MBP fusion protein consisting of the
Cut repeat 3 and the Cut homeodomain (C). The black
arrowheads indicate the specific DNA-protein complexes, the
black arrow highlights unspecific DNA-protein complex. Loading
of equal amounts of labeled wild-type and mutated oligonucleo-
tides is illustrated by formation of comparable amounts of
unspecific DNA-protein complex (indicated by black arrow).
(JPG)
Figure S2 Ct represses rpr transcription and apoptosis activation.
(A–F) rpr RNA expression in stage 11 wild-type (A, C, E), ct
db7 (B,
D) and arm::ct (F) embryos. rpr transcription is ectopically activated
in the posterior spiracle primordium (B) and the gut primordium
(D) in ct mutant embryos (marked by red arrowheads), and is
globally repressed when Ct is ubiquitously mis-expressed (F). (G,
H) Acridine Orange (AO) staining of stage 13 wild-type (G) and ct
mutant (H) embryos highlights up-regulation of programmed cell
death in the PS primordium of ct mutant embryos. (I–N) hid (I, J),
grim (K, L), skl (M, N) RNA expression in stage 11 wild-type (I, K,
M) and ct
db7 (J, L, N) mutant embryos. Red boxes indicate
posterior spiracle primordium in respective embryos.
(JPG)
Figure S3 Cut directly represses rpr and apoptosis in the PS
primordium. (A–D) GFP expression in the posterior spiracle
primordium of different reporter lines at developmental stage 15.
Spalt (Sal) and Cut (Ct) proteins label stigmatophore (blue) or
spiracular chamber and filzko ¨rper precursor cells (red). Closed,
yellow arrowheads in (C) and (D) mark reporter gene expression in
filzko ¨rper cells, whereas open, yellow arrowheads in (A) and (B)
mark missing GFP expression. (E–H) Single color images of the
different reporter lines showing only Sal expression. (I–L) Single
color images of the different reporter lines showing only Ct
expression. (M–P) Single color images of the different reporter
lines showing only GFP expression.
(JPG)
Figure S4 Location and conservation of the rpr-HRE-571
element. (A) Conservation graph of the rpr intergenic region
obtained from the UCSC genome browser (http://genome.ucsc.
edu/). The rpr-HRE-571 element, which is marked by a light-red
box (3 L: 18384438..18385008), is located 6 kb downstream of the
rpr coding sequence (marked by a dark-red box). The coding
region of the pro-apoptotic gene grim is marked by a dark-blue
box. (B) Alignment of the rpr-HRE-571 region from five different
Drosophila species (D. melanogaster, D. yakuba, D. pseudoobscura, D.
virilis, D. grimshawi). Abd-B binding sites are marked by purple, Ct
binding sites by orange boxes.
(JPG)
Figure S5 Ct function is required for filzko ¨rper differentiation.
The following genotypes are shown: wild type (A, D and G), ct
db7;
ems::GFP (B, E and H) and ct
db7; ems::p35;GFP (C, F and I). (A–C)
Cuticle preparations of the different genotypes with focus on the
posterior spiracle of 1
st instar Drosophila larvae. Closed, orange
arrowhead in (A) marks the filzko ¨rper, whereas open, orange
arrowheads in (B) and (C) indicate the absence of this structure in
the respective genotypes. (D–F) Ct and Crb stainings in the
respective embryos are shown to highlight the morphology of the
filzko ¨rper in the different genotypes. (G–I) DE-Cad staining in the
respective genotypes. Closed, red arrowheads in (G) indicate the
presence of the filzko ¨rper, whereas open, red arrowheads in (H)
and (I) highlight the absence of this structure in ct
db7; ems::GFP (H)
and ct
db7; ems::p35;GFP (I) embryos.
(JPG)
Figure S6 Ct represses apoptosis in wing margin bristles and in
external sensory organs of the notum. (A–D) Close-up of Drosophila
notum in wild-type (A), Eq::ct
RNAi (B), Eq::ct
RNAi; p35 (C) and in
Eq::ct
RNAi; rpr
RNAi animals (D). Open, yellow circles in (B, C and
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yellow circle in (A) highlights the presence of these structures in
the different genotypes. Note that in (B) most bristles are missing,
whereas in (C) and (D) some bristles form, which have cell
polarity defects. Expression of Cut in mechanosensory organs of
the notum has been shown before [63]. (E–H) Close-up of
Drosophila adult wing with focus on wing margin between the wing
veins L2 and L3 in wild-type (E), C96::ct
RNAi (F), C96::ct
RNAi; p35
(G) and in C96::ct
RNAi; rpr
RNAi (H) animals. Closed, blue
arrowheads in (E), (G) and (H) highlight the presence of
mechanosensory bristles at the wing margin, whereas the open,
blue arrowhead in (F) marks their absence in the respective
genotype. Importance of Cut function for wing margin
development has been shown before [64,65,66,67]. Despite the
fact that Cut is expressed in a narrow region along the wing
margin [64,65,66,67], we observed a loss of cells outside that
region. One likely explanation for this phenotype is the known
requirement of Cut to maintain expression of the secreted factor
Wingless (Wg) at the wing margin [64,65,66,67], thus we assume
that neighboring cells which normally receive the Wg signal
undergo apoptosis in a cell non-autonomous manner. (I, J)
Quantification of mechanosensory bristles on notum (I) and
between wing veins L2 and L3 (J) in the different genetic
backgrounds. 15–20 flies were scored for each genotype.
(JPG)
Figure S7 Invasiveness of Ct depleted cells. (A–D) Co-
localization of the eye differentiation marker Embryonic Lethal
Abnormal Vision (ELAV) and the proliferation marker Phosphor-
ylated histone H3 (PH3) in 3rd instar eye-antennal discs. Blue
circle in (D) marks loss of ELAV expression in eyeful::ct
RNAi 3
rd
instar eye-antennal discs, yellow circle in (B) marks ELAV-positive
cells at ectopic location in eyeful::ct
RNAi;p35 3
rd instar eye-antennal
discs.
(JPG)
Figure S8 Simultaneous regulation of differentiation and
apoptosis represents a general cancer prevention mechanism.
Top: Representative pictures of tumorous eye growth in flies of
indicated genotypes. Bottom: Quantification of primary tumor
growth in the respective genotypes. Genes tested were selected
based on their function as cell-type specifying transcriptional
regulators active in the Drosophila eye. Genes: vvl: ventral veins lacking;
gro: groucho; ct: cut; H: Hairless.
(JPG)
Table S1 Putative binding sites for vertebrate Cux1 within the
non-coding regions of the puma gene.
(DOC)
Acknowledgments
We thank Maria Domiguez, James Castelli-Gair Hombria, Yuh Nung Jan,
Jean-Paul Vincent, Barry Dickson, Haiwei Pi, Rosa Barrio, Michael
Boutros, Bloomington Stock Center, Vienna Drosophila RNAi Center
(VDRC), and Developmental Studies Hybridoma Bank at the University of
Iowa for providing material; the Gene Core facility at EMBL Heidelberg
for microarray experiments; the Nikon Imaging Center for microscopy;
Petra Stoebe for EMSA; and Michael Boutros, Jan U. Lohmann, Alexis
Maizel, Bill McGinnis, Bernard M. Mechler, Athanasios G. Papavassiliou,
and Jochen Wittbrodt for critically reading the manuscript.
Author Contributions
Conceived and designed the experiments: ZZ IL AH-B NB. Performed the
experiments: ZZ SS NH AH-B NB DB. Analyzed the data: ZZ NH IL AH-
B NB FP DB. Contributed reagents/materials/analysis tools: IL. Wrote the
paper: FP IL.
References
1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57–70.
2. Harris H (2005) A long view of fashions in cancer research. Bioessays 27:
833–838.
3. Shah N, Sukumar S (2010) The Hox genes and their roles in oncogenesis. Nat
Rev Cancer 10: 361–370.
4. Bossuyt W, De Geest N, Aerts S, Leenaerts I, Marynen P, et al. (2009) The
Atonal proneural transcription factor links differentiation and tumor formation
in Drosophila. PLoS Biol 7: e40. doi:10.1371/journal.pbio.1000040.
5. Vidal M, Cagan RL (2006) Drosophila models for cancer research. Curr Opin
Genet Dev 16: 10–16.
6. Portt L, Norman G, Clapp C, Greenwood M, Greenwood MT (2011) Anti-
apoptosis and cell survival: A review. Biochim Biophys Acta.
7. Pitsouli C, Perrimon N (2010) Embryonic multipotent progenitors remodel the
Drosophila airways during metamorphosis. Development 137: 3615–3624.
8. Werz C, Lee TV, Lee PL, Lackey M, Bolduc C, et al. (2005) Mis-specified cells
die by an active gene-directed process, and inhibition of this death results in cell
fate transformation in Drosophila. Development 132: 5343–5352.
9. Hu N, Castelli-Gair J (1999) Study of the posterior spiracles of Drosophila as a
model to understand the genetic and cellular mechanisms controlling
morphogenesis. Dev Biol 214: 197–210.
10. Goyal L, McCall K, Agapite J, Hartwieg E, Steller H (2000) Induction of
apoptosis by Drosophila reaper, hid and grim through inhibition of IAP function.
EMBO J 19: 589–597.
11. Bardet PL, Kolahgar G, Mynett A, Miguel-Aliaga I, Briscoe J, et al. (2008) A
fluorescent reporter of caspase activity for live imaging. Proc Natl Acad Sci U S A
105: 13901–13905.
12. Hay BA, Wolff T, Rubin GM (1994) Expression of baculovirus P35 prevents cell
death in Drosophila. Development 120: 2121–2129.
13. Merabet S, Catala F, Pradel J, Graba Y (2002) A green fluorescent protein
reporter genetic screen that identifies modifiers of Hox gene function in the
Drosophila embryo. Genetics 162: 189–202.
14. Nepveu A (2001) Role of the multifunctional CDP/Cut/Cux homeodomain
transcription factor in regulating differentiation, cell growth and development.
Gene 270: 1–15.
15. Hilgers V, Bushati N, Cohen SM. Drosophila microRNAs 263a/b confer
robustness during development by protecting nascent sense organs from
apoptosis. PLoS Biol 8: e1000396. doi:10.1371/journal.pbio.1000396.
16. Ferres-Marco D, Gutierrez-Garcia I, Vallejo DM, Bolivar J, Gutierrez-Avino FJ,
et al. (2006) Epigenetic silencers and Notch collaborate to promote malignant
tumours by Rb silencing. Nature 439: 430–436.
17. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, et al. (2007) Mutational
loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat
Med 13: 1203–1210.
18. Willecke M, Toggweiler J, Basler K. Loss of PI3K blocks cell-cycle progression
in a Drosophila tumor model. Oncogene 30: 4067–4074.
19. Pagliarini RA, Xu T (2003) A genetic screen in Drosophila for metastatic
behavior. Science 302: 1227–1231.
20. Mohamet L, Hawkins K, Ward CM (2011) Loss of function of E-cadherin in
embryonic stem cells and the relevance to models of tumorigenesis. J Oncol
2011: 352616.
21. Bokel C, Brown NH (2002) Integrins in development: moving on, responding to,
and sticking to the extracellular matrix. Dev Cell 3: 311–321.
22. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis.
Science 331: 1559–1564.
23. Sansregret L, Nepveu A (2008) The multiple roles of CUX1: insights from
mouse models and cell-based assays. Gene 412: 84–94.
24. Quaggin SE, Yeger H, Igarashi P (1997) Antisense oligonucleotides to Cux-1, a
Cut-related homeobox gene, cause increased apoptosis in mouse embryonic
kidney cultures. J Clin Invest 99: 718–724.
25. Ripka S, Neesse A, Riedel J, Bug E, Aigner A, et al. (2010) CUX1: target of Akt
signalling and mediator of resistance to apoptosis in pancreatic cancer. Gut 59:
1101–1110.
26. Sinclair AM, Lee JA, Goldstein A, Xing D, Liu S, et al. (2001) Lymphoid
apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant
mice. Blood 98: 3658–3667.
27. Woodhouse EC, Liotta LA (2004) Drosophila invasive tumors: a model for
understanding metastasis. Cell Cycle 3: 38–40.
28. Yu J, Wang P, Ming L, Wood MA, Zhang L (2007) SMAC/Diablo mediates the
proapoptotic function of PUMA by regulating PUMA-induced mitochondrial
events. Oncogene 26: 4189–4198.
29. Zhou L, Schnitzler A, Agapite J, Schwartz LM, Steller H, et al. (1997)
Cooperative functions of the reaper and head involution defective genes in the
programmed cell death of Drosophila central nervous system midline cells. Proc
Natl Acad Sci U S A 94: 5131–5136.
Apoptosis Regulation in Development and Disease
PLoS Genetics | www.plosgenetics.org 13 March 2012 | Volume 8 | Issue 3 | e100258230. Portales-Casamar E, Thongjuea S, Kwon AT, Arenillas D, Zhao X, et al. (2010)
JASPAR 2010: the greatly expanded open-access database of transcription
factor binding profiles. Nucleic Acids Res 38: D105–110.
31. Certel K, Anderson MG, Shrigley RJ, Johnson WA (1996) Distinct variant
DNA-binding sites determine cell-specific autoregulated expression of the
Drosophila POU domain transcription factor Drifter in midline glia or trachea.
Mol Cell Biol 16: 1813–1823.
32. Inbal A, Levanon D, Salzberg A (2003) Multiple roles for u-turn/ventral veinless in
the development of Drosophila PNS. Development 130: 2467–2478.
33. Conradt B (2009) Genetic control of programmed cell death during animal
development. Annu Rev Genet 43: 493–523.
34. Baehrecke EH (2002) How death shapes life during development. Nat Rev Mol
Cell Biol 3: 779–787.
35. Igaki T (2009) Correcting developmental errors by apoptosis: lessons from
Drosophila JNK signaling. Apoptosis 14: 1021–1028.
36. McNeill H, Downward J (1999) Apoptosis: Ras to the rescue in the fly eye. Curr
Biol 9: R176–179.
37. Richardson H, Kumar S (2002) Death to flies: Drosophila as a model system to
study programmed cell death. J Immunol Methods 265: 21–38.
38. Molchadsky A, Rivlin N, Brosh R, Rotter V, Sarig R (2010) p53 is balancing
development, differentiation and de-differentiation to assure cancer prevention.
Carcinogenesis 31: 1501–1508.
39. Schmeichel KL (2004) A fly’s eye view of tumor progression and metastasis.
Breast Cancer Res 6: 82–83.
40. Balzer EM, Konstantopoulos K (2011) Intercellular adhesion: mechanisms for
growth and metastasis of epithelial cancers. Wiley Interdiscip Rev Syst Biol Med.
41. Wirtz D, Konstantopoulos K, Searson PC (2011) The physics of cancer: the role
of physical interactions and mechanical forces in metastasis. Nat Rev Cancer 11:
512–522.
42. Michl P, Downward J (2006) CUTL1: a key mediator of TGFbeta-induced
tumor invasion. Cell Cycle 5: 132–134.
43. Harada R, Berube G, Tamplin OJ, Denis-Larose C, Nepveu A (1995) DNA-
binding specificity of the cut repeats from the human Cut-like protein. Mol Cell
Biol 15: 129–140.
44. Iulianella A, Sharma M, Vanden Heuvel GB, Trainor PA (2009) Cux2 functions
downstream of Notch signaling to regulate dorsal interneuron formation in the
spinal cord. Development 136: 2329–2334.
45. Sharma M, Fopma A, Brantley JG, Vanden Heuvel GB (2004) Coexpression of
Cux-1 and Notch signaling pathway components during kidney development.
Dev Dyn 231: 828–838.
46. Verhagen AM, Vaux DL (2002) Cell death regulation by the mammalian IAP
antagonist Diablo/Smac. Apoptosis 7: 163–166.
47. Chipuk JE, Green DR (2009) PUMA cooperates with direct activator proteins to
promote mitochondrial outer membrane permeabilization and apoptosis. Cell
Cycle 8: 2692–2696.
48. Wasserman WW, Sandelin A (2004) Applied bioinformatics for the identification
of regulatory elements. Nat Rev Genet 5: 276–287.
49. Noyes MB, Christensen RG, Wakabayashi A, Stormo GD, Brodsky MH, et al.
(2008) Analysis of homeodomain specificities allows the family-wide prediction of
preferred recognition sites. Cell 133: 1277–1289.
50. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, et al. (2005)
Evolutionarily conserved elements in vertebrate, insect, worm, and yeast
genomes. Genome Res 15: 1034–1050.
51. Lovegrove B, Somoes S, Rivas ML, Sotillos S, Johnson K, et al. (2006) Co-
ordinated control of cell adhesion, cell polarity and cytoskeleton underlies Hox
induced organogenesis in Drosophila. Curr Biol 16: 2206–2216.
52. Pi H, Wu HJ, Chien CT (2001) A dual function of phyllopod in Drosophila
external sensory organ development: cell fate specification of sensory organ
precursor and its progeny. Development 128: 2699–2710.
53. Grueber WB, Jan LY, Jan YN (2003) Different levels of the homeodomain
protein Cut regulate distinct dendrite branching patterns of Drosophila multi-
dendritic neurons. Cell 112: 805–818.
54. Hueber SD, Bezdan D, Henz SR, Blank M, Wu H, et al. (2007) Comparative
analysis of Hox downstream genes in Drosophila. Development 134: 381–392.
55. Lohmann I, McGinnis N, Bodmer M, McGinnis W (2002) The Drosophila Hox
gene Deformed sculpts head morphology via direct regulation of the apoptosis
activator reaper. Cell 110: 457–466.
56. Stobe P, Stein SM, Habring-Muller A, Bezdan D, Fuchs AL, et al. (2009)
Multifactorial regulation of a Hox target gene. PLoS Genet 5: e1000412.
doi:10.1371/journal.pgen.1000412.
57. Zhai Z, Stein MA, Lohmann I (2009) Expression of the apoptosis gene reaper in
homeotic, segmentation and other mutants in Drosophila. Gene Expr Patterns 9:
357–363.
58. Barolo S, Carver LA, Posakony JW (2000) GFP and b-galactosidase
transformation vectors for promoter/enhancer analysis in Drosophila. Biotechni-
ques 29: 726–732.
59. Boy AL, Zhai Z, Habring-Muller A, Kussler-Schneider Y, Kaspar P, et al. (2010)
Vectors for efficient and high-throughput construction of fluorescent Drosophila
reporters using the PhiC31 site-specific integration system. Genesis 48: 452–456.
60. Kosman D, Mizutani CM, Lemons D, Cox WG, McGinnis W, et al. (2004)
Multiplex detection of RNA expression in Drosophila embryos. Science 305: 846.
61. Zhai Z, Fuchs AL, Lohmann I (2010) Cellular analysis of newly identified Hox
downstream genes in Drosophila. Eur J Cell Biol 89: 273–278.
62. Stratigopoulos G, LeDuc CA, Cremona ML, Chung WK, Leibel RL (2011)
Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-
associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like
(RPGRIP1L) genes and coordinates leptin receptor signaling. J Biol Chem 286:
2155–2170.
63. Blochlinger K, Jan LY, Jan YN (1993) Postembryonic patterns of expression of
cut, a locus regulating sensory organ identity in Drosophila. Development 117:
441–450.
64. Jack J, DeLotto Y (1995) Structure and regulation of a complex locus: the cut
gene of Drosophila. Genetics 139: 1689–1700.
65. Krupp JJ, Yaich LE, Wessells RJ, Bodmer R (2005) Identification of genetic loci
that interact with cut during Drosophila wing-margin development. Genetics 170:
1775–1795.
66. Micchelli CA, Rulifson EJ, Blair SS (1997) The function and regulation of cut
expression on the wing margin of Drosophila: Notch, Wingless and a dominant
negative role for Delta and Serrate. Development 124: 1485–1495.
67. Ludlow C, Choy R, Blochlinger K (1996) Functional analysis of Drosophila and
mammalian Cut proteins in flies. Dev Biol 178: 149–159.
Apoptosis Regulation in Development and Disease
PLoS Genetics | www.plosgenetics.org 14 March 2012 | Volume 8 | Issue 3 | e1002582